Prognostic value of expression of p53, proliferating cell nuclear antigen, and c-erbB-2 in laryngeal carcinoma

Medical Science Monitor

Volumn 14, Issue 6, 2008, Pages

  Micozkadioǧlu, Deniz ^a   Ünal, Murat ^a,b   Pata, Yavuz Selim ^a   Baştürk, Mine ^a   Cinel, Leyla ^a  

^a MERSIN UNIVERSITY   (Turkey)

^b MERSIN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

c erbB 2; Laryngeal squamous cell carcinoma; p53; PCNA

Indexed keywords

CYCLINE; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; GENE OVEREXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; LARYNX MUCOSA; LYMPH NODE METASTASIS; MALE; MALIGNANT TRANSFORMATION; PROGNOSIS; PROTO ONCOGENE; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ADULT; AGED; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTOR, ERBB-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 46449104180     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Cann IC, Fried MP, Rothman KJ: Epidemiology of squamous cell cancer of the head and neck. Otolaryngol Clin North Am, 1985; 18: 367-88
2. Cattaruzza MS, Maisonneuve P, Boyle P: Epidemiology of laryngeal cancer. Eur J Cancer B Oral Oncol, 1996; 32B: 293-305
3. Soussi T, Legros Y, Lubin R et al: Multifactorial analysis of p53 alteration in human cancer: a review. Int J Cancer, 1994; 57: 1-9
4. Sarac S, Ayhan A, Hosal AS, Kaya S: Prognostic significance of PCNA expression in laryngeal cancer. Arch Otolaryngol Head Neck Surg, 1998; 124: 1321-24
5. Krecicki T, Jelen M, Zalesska-Krecicka M et al: Epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and Ki-67 antigen in laryngeal epithelial lesions. Oral Oncol, 1999; 35: 180-86
6. Giatromanolaki A, Koukourakis MI, Sivridis E, Fountzilas G: c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival. Anticancer Res, 2000; 20: 997-1004
7. Krecicki T, Jelen M, Zalesska-Krecicka M: C-erbB-2 immunostaining in laryngeal cancer. Acta Otolaryngol, 1999; 119: 392-95
8. Klatka J: Prognostic value of the expression of p53 and bcl-2 in patients with laryngeal carcinoma. Eur Arch Otorhinolaryngol, 2001; 258: 537-41
9. Williams GT: Programmed cell death: apoptosis and oncogenesis. Cell, 1991; 65: 1097-98
10. Yilmaz T, Hosal AS, Gedikoglu G, Kaya S: Prognostic significance of histopathological parameters in cancer of the larynx. Eur Arch Otorhinolaryngol, 1999; 256: 139-44
11. Kazkayasi M, Hucumenoglu S, Sinner GI, Hucumenoglu M: Over-expression of p53 and c-erbB-2 oncoproteins in laryngeal carcinoma. Eur Arch Otorhinolaryngol, 2001; 258: 329-35
12. Yildirim S, Cermik H, Isitmangil T et al: Significance of p53 and bcl-2 immunoexpression in the prognosis of laryngeal squamous cell carcinoma. J Int Med Res, 2002; 30: 597-600
13. Calli C, Calli A, Pinar E et al: Expression of Ki-67 and p53 in laryngeal squamous cell carcinomas. Kulak Burun Bogaz Ihtis Derg, 2005; 15: 9-13
14. Friedman M, Lim JW, Manders E et al: Prognostic significance of Bcl-2 and p53 expression in advanced laryngeal squamous cell carcinoma. Held Neck, 2001; 23: 280-85
15. Spafford MF, Koeppe J, Pan Z et al: Correlation of tumor markers p53, bcl-2, CD34, CD44H, CD44v6, and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg, 1996; 122: 627-32
16. Vielba R, Bilbao J, Ispizua A et al: p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx. Laryngoscope, 2003; 113: 167-72
17. Unal M, Bilir A, Karatay MC: Thymidine labeling index in laryngeal squamous cell carcinoma in correlation with pTNM, age, histological grade and recurrence. ORL J Otorhinolaryngol Relat Spec, 2002; 64: 257-62
18. Krecicki T, Jelen M: Proliferating cell nuclear antigen in laryngeal cancer. J Laryngol Otol, 1998; 112: 310-13
19. Georgiou A, Gomatos IP, Pararas NB et al: Cell kinetics and apoptosis in laryngeal carcinoma patients. Ann Otol Rhinol Laryngol, 2003; 112: 206-13
20. Boran C, Yildiz L, Kandemir B et al: Correlation of proliferating cell nuclear antigen and bcl-2 expression with tumor front grading and metastasis in laryngeal squamous cell carcinoma. Neoplasma, 2003; 50: 139-43
21. Liu M, Lawson G, Delos M et al: Prognostic value of cell proliferation markers, tumour suppressor proteins and cell adhesion molecules in primary squamous cell carcinoma of the larynx and hypopharynx. Eur Arch Otorhinolaryngol, 2003; 260: 28-34
22. Guerry M, Vabre L, Talbot M et al: Prognostic value of histological and biological markers in pharyngeal squamous cell carcinoma: a case-control study. Br J Cancer, 1998; 77: 1932-36
23. Tantawy A, Youins L, Hamza M: Expression of c-erb B-2 oncoprotein in cancer of the larynx in relation to invasion of the cartilagenous framework and prognosis. Eur Arch Otorhinolaryngol, 1999; 256: 72-77